![Roger Hajjar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 48 369 $ al 31/07/2026
Dr. Roger J.
Hajjar, MD, is an Independent Director at Longeveron, Inc., a Director-Gene & Cell Therapy at Mass General Brigham, Inc., a President, Director & Chief Medical Officer at Medera, Inc., a Chief Executive Officer at Sardocor Corp., a Head-Research & Development at Ring Therapeutics, Inc. and a President, Chief Medical Officer & Director at Medera, Inc. /New/.
He is on the Board of Directors at Longeveron, Inc., Atamyo Therapeutics SAS, Medera, Inc. and Medera, Inc. /New/.
Dr. Hajjar was previously employed as a Director-Cardiovascular Research Center by Icahn School of Medicine at Mount Sinai and a Director-Cardiovascular Research by Celladon Corp.
He also served on the board at Cellectis SA. He received his undergraduate degree from The Johns Hopkins University and a doctorate degree from Harvard Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LONGEVERON INC. CLASS A 0,23 % | 19/08/2026 | 69.000 ( 0,23 % ) | 48 369 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LONGEVEROPAR | Director/Miembro de la Junta | 02/07/2024 |
Atamyo Therapeutics SAS
 Atamyo Therapeutics SAS BiotechnologyHealth Technology Develops gene therapies for neuromuscular diseases | Director/Miembro de la Junta | 24/07/2023 |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides patient care, medical research and discovery & teaching services | Corporate Officer/Principal | 01/12/2022 |
Medera, Inc.
 Medera, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on eradicating cardiovascular diseases | Fundador | 01/01/2014 |
Sardocor Corp.
 Sardocor Corp. Sardocor Corp. is a company based in Boston, MA. The company was founded in 2019. | Director Ejecutivo | - |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Director Técnico/Científico/I+D | - |
| Empresas | Cargo | Fin |
|---|---|---|
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2019 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Fundador | - |
| CELLECTIS S.A. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Mass General Brigham, Inc.
Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides patient care, medical research and discovery & teaching services | Commercial Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Atamyo Therapeutics SAS
Atamyo Therapeutics SAS BiotechnologyHealth Technology Develops gene therapies for neuromuscular diseases | Health Technology |
Medera, Inc.
Medera, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on eradicating cardiovascular diseases | Health Technology |
Sardocor Corp.
Sardocor Corp. Sardocor Corp. is a company based in Boston, MA. The company was founded in 2019. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
